GLP-1 Pill vs Injection: Which Is Better for Weight Loss?

Last reviewed: 19 September 2026

Pill vs injection at a glance

Which GLP-1 weight-loss drugs come as a pill?

Two: Wegovy tablets (semaglutide) and Foundayo (orforglipron), both taken once a day and both indicated for adults with obesity, or overweight with at least one weight-related condition. Foundayo’s label is dated August 2026, and Wegovy’s label added tablets alongside the injection.

Rybelsus is also an oral semaglutide tablet, but it is approved for type 2 diabetes, not weight loss. Its label now covers a second brand, Ozempic tablets, and warns that the two are “not substitutable on a mg-to-mg basis”. Which GLP-1s are FDA-approved for weight loss has the full list with approved ages.

Which are injections, and how often do you inject?

Three: Wegovy and Zepbound once a week, and Saxenda once a day. Wegovy’s label says to inject “once weekly, on the same day each week, at any time of day, with or without meals”, under the skin of the abdomen, thigh or upper arm, rotating the site each time. Saxenda’s says once daily at any time of day, without regard to meals.

Zepbound comes as a single-dose pen, a KwikPen for single-patient use and a vial. Wegovy comes as a single-dose pen, including the 7.2 mg Wegovy HD pen, a single-dose syringe and a single-patient-use pen.

Do GLP-1 pills work as well as injections?

For semaglutide, the label trials landed close together: an average 13.6% weight reduction at 64 weeks with Wegovy 25 mg tablets against 2.4% on placebo, and 14.9% at 68 weeks with the 2.4 mg injection against 2.4%. In the tablet trial 76.3% of patients lost at least 5% of body weight; in the injection trial 83.5% did.

The largest averages in any label belong to an injection. Zepbound showed 15.0%, 19.5% and 20.9% at 5, 10 and 15 mg over 72 weeks, against 3.1% on placebo. Foundayo, the other tablet, showed 7.4%, 8.3% and 11.1% at 5.5, 9 and 17.2 mg over 72 weeks, against 2.1%. Saxenda showed 7.4% at 56 weeks against 3.0%.

Three cautions apply. These trials were run separately, with different patients and lengths, so the numbers are not a head-to-head ranking. Every trial paired the drug with a reduced-calorie diet and increased physical activity. And an average hides a spread: in the Wegovy injection trial 16.5% of treated patients lost less than 5% of their body weight. These are not typical individual results.

Do GLP-1 pills cost less than injections?

At the manufacturers’ self-pay prices read on October 1, 2026, the two pills have the lowest starting price in the class, $149 a month, and the gap widens at the top doses. Novo Nordisk prices the Wegovy pill at $149 a month for 1.5 mg, $199 for 4 mg and $299 for 9 mg and 25 mg. Lilly prices Foundayo at $149 for 0.8 mg and 2.5 mg, $199 for 5.5 mg and $299 for 9 mg, and $299 for 14.5 mg and 17.2 mg when you refill within 45 days; it says the 2.5 mg and 5.5 mg prices are temporarily reduced through December 31, 2026.

The injections start higher. The Wegovy pen is $199 a month for the first two fills for new patients through December 31, 2026, then $349, and $399 for the 7.2 mg HD pen. Zepbound is $299 at 2.5 mg, $399 at 5 mg and $449 from 7.5 mg if you refill within 45 days; Lilly’s terms put the regular price at $499 for 7.5 mg and $699 from 10 mg. Pen needles, or a needle and syringe for the vial, are bought separately.

So at the top doses: Wegovy pill $299, Foundayo $299 (14.5 to 17.2 mg, with refills within 45 days), Wegovy pen $349 ($399 HD), and Zepbound $449 with on-time refills or $499 to $699 at the regular price. These prices cover medication only, so add the prescriber. What GLP-1s cost in 2026 sets out every route including insurance and Medicare, and what a GLP-1 program really costs per month adds the program fees. Compounded oral GLP-1s sold by telehealth programs are not FDA-approved; see compounded oral GLP-1s below.

How do you take a GLP-1 pill?

The two tablets have very different rules. Wegovy tablets must be taken “on an empty stomach in the morning with water (up to 4 ounces)”, swallowed whole, followed by a wait of “at least 30 minutes before eating food, drinking beverages or taking other oral medications”. The label explains why: the tablet is co-formulated with an absorption enhancer called SNAC, absorption happens mainly in the stomach, and only about 1% to 2% of the semaglutide is absorbed.

Foundayo can be taken “with or without food”. Its label says to swallow tablets whole and not to break, crush or chew them.

If your mornings are irregular, or you take other morning medications that cannot wait 30 minutes, that difference matters more than the trial numbers.

Foundayo vs Wegovy pill

The two approved tablets differ most in routine. Wegovy tablets need an empty stomach in the morning, up to 4 ounces of water and a 30-minute wait; Foundayo can be taken with or without food. In their separate label trials Wegovy tablets averaged 13.6% weight loss at 64 weeks and Foundayo up to 11.1% at 72 weeks. Both store at 68°F to 77°F, and both start at $149 a month self-pay. Foundayo vs Wegovy pill: the full comparison goes dose by dose.

How long does it take to reach the full dose?

About three to five months, and longer if you need to slow down for side effects. Every label escalates gradually “to reduce the risk of gastrointestinal adverse reactions”.

• Wegovy injection: 0.25 mg for weeks 1 to 4, 0.5 mg for weeks 5 to 8, 1 mg for weeks 9 to 12, 1.7 mg for weeks 13 to 16, then the maintenance dose from week 17.
• Wegovy tablets: 1.5 mg for days 1 to 30, 4 mg for days 31 to 60, 9 mg for days 61 to 90, then 25 mg from day 91.
• Zepbound: 2.5 mg weekly for 4 weeks, then 5 mg, with further 2.5 mg increases after at least 4 weeks on each dose. The 2.5 mg dose “is not approved as a maintenance dosage”.
• Foundayo: 0.8 mg daily, then 2.5 mg and 5.5 mg after at least 30 days on each, with later steps to 9, 14.5 or 17.2 mg.
• Saxenda: 0.6 mg a day for one week, raised weekly until 3 mg.

Self-pay prices rise with these steps. Why the price goes up after the first months sets out each manufacturer’s dose tiers.

How do you store GLP-1 pills and pens?

Tablets are stored at room temperature; pens belong in the refrigerator. Wegovy tablets and Foundayo are both labeled for 68°F to 77°F, and Wegovy tablets must stay in the original bottle to protect them from moisture.

The Wegovy pen is stored at 36°F to 46°F. Before the cap is removed it can be kept at 46°F to 86°F for up to 28 days, and it must be thrown away if frozen, exposed to temperatures above 86°F, or out of the refrigerator for 28 days or longer. An unopened Zepbound vial kept at room temperature must be discarded after 30 days.

Tablets are simpler for travel and for anyone without reliable refrigeration. The FDA advises patients not to use any injectable GLP-1 that arrives warm or with insufficient refrigeration.

Are side effects different for pills and injections?

The main side effects are shared across the class: nausea, diarrhea, vomiting and constipation lead every label’s adverse reaction table. One category is unique to injections. Zepbound’s label reports injection site reactions in 6% to 8% of patients against 2% on placebo.

Gallstones were reported slightly more often with the tablet than the injection in Wegovy’s trials: 2.5% of tablet-treated patients against 1% on placebo, and 1.6% of injection-treated patients against 0.7%. GLP-1 side effects: what the labels report gives the full rates and the symptoms that need a clinician.

Are compounded oral GLP-1s the same as the approved pills?

No. Compounded oral semaglutide or tirzepatide, sold as tablets, drops, sublingual forms or gummies, is not FDA-approved, and the FDA says it does not review compounded drugs for safety, effectiveness or quality. The approved Wegovy tablet depends on a specific absorption enhancer and still delivers only 1% to 2% of its dose, so an oral formulation without published absorption data is an unknown.

Several programs DoIQualify reviews list compounded oral options, including MEDVi, Direct Meds and Eden. Ask which oral form it is and what evidence supports it. Compounded vs brand-name GLP-1s explains the regulatory gap.

How do you choose between a pill and an injection?

Use decision rules, then let a clinician confirm. A licensed clinician makes every prescribing decision.

• You cannot or will not self-inject: the tablets are the FDA-approved route.
• You cannot keep a strict empty-stomach morning routine: Foundayo or a weekly injection fits better than Wegovy tablets.
• You want the fewest doses: a weekly injection is 52 doses a year against 365 tablets.
• You travel often or lack reliable refrigeration: tablets store at room temperature.
• The largest trial averages matter most to you: Zepbound’s label reports them, with the caution that trials are not head-to-head.

The DoIQualify quiz asks whether you prefer a non-injection option and shows programs that offer one. It shows whether you may meet common criteria; a result is not an approval. The compare table marks which programs offer oral, injectable, compounded and brand-name medication.

GLP-1 pills and injections FAQ

This article is informational and not medical advice. A licensed clinician makes every prescribing decision. Medical disclaimer